Stocktoria
DarioHealth Corp. DRIO
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2013-03-08
DarioHealth Corp. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $22.4M | $27.0M | $20.4M | $27.7M | $20.5M |
| Gross profit | $12.7M | $13.3M | $6.0M | $9.7M | $4.0M |
| R&D expense | $13.8M | $24.2M | $20.2M | $19.6M | $17.2M |
| Operating income | -$36.7M | -$57.7M | -$56.2M | -$56.8M | -$76.5M |
| Income tax | $105,000 | -$1.9M | $64,000 | $4,000 | $32,000 |
| Net income | -$41.7M | -$42.7M | -$59.4M | -$62.2M | -$76.8M |
| EPS (diluted) | $10.12 | $12.27 | $1.93 | $2.54 | $4.07 |
| Operating cash flow | -$25.9M | -$38.6M | -$30.4M | -$47.8M | -$50.4M |
| Free cash flow | -$26.1M | -$38.7M | -$31.0M | -$48.3M | -$50.7M |
| Cash & equivalents | $21.8M | $27.8M | $36.8M | $49.4M | $35.8M |
| Inventory | $4.3M | $4.8M | $5.1M | $8.0M | $6.2M |
| Total assets | $110.1M | $118.9M | $96.4M | $119.2M | $100.8M |
| Shareholders' equity | $67.9M | $72.0M | $58.1M | $80.0M | $85.5M |
Source: SEC EDGAR filings · CIK 0001533998 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.